Keros Therapeutics (KROS) Free Cash Flow Growth (3y) (2022 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -4.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.51% |
| Sep 30, 2025 | 27.55% |
| Jun 30, 2025 | -8.87% |
| Mar 31, 2025 | 376.34% |
| Dec 31, 2024 | -32.90% |
| Sep 30, 2024 | -30.02% |
| Jun 30, 2024 | -29.27% |
| Mar 31, 2024 | -62.15% |
| Dec 31, 2023 | -47.81% |
| Sep 30, 2023 | -44.24% |
| Jun 30, 2023 | -47.87% |
| Mar 31, 2023 | -60.43% |
| Dec 31, 2022 | -60.18% |
| Sep 30, 2022 | -100.81% |
| Jun 30, 2022 | -62.99% |
| Mar 31, 2022 | 15.54% |